Analyst Travis Steed works at BAML and is covering the the Healthcare sector with 141 price targets and ratings documented since 2017 spanning on 18 stocks. Previously, Travis Steed worked at CANTOR FITZGERALD.
Travis Steed's average stock forecast success ratio is 55.9% with an average time for price targets to be met of 159.39 days.
Most recent stock forecast was given on BDX, Becton, Dickinson and Company at 08-May-2023.
Analyst best performing recommendations are on LUNG (PULMONX CORP.).
The best stock recommendation documented was for LUNG (PULMONX CORP.) at 1/3/2023. The price target of $8 was fulfilled within 1 day with a profit of $0.51 (6.81%) receiving and performance score of 68.09.
Average potential price target upside
Currently, out of the existing stock ratings of Travis Steed - 2 which are a Hold (22.22%), 4 which are a Buy (44.44%), 3 which are a Sell (33.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
112
$10.34 (10.17%)
146
9 days ago
6/8 (75%)
$13.71 (20.86%)
441
Buy
130
$28.34 (27.88%)
123
1 months 22 days ago
0/3 (0%)
$22.14 (21.25%)
Buy
116
$14.34 (14.11%)
123
1 months 22 days ago
11/17 (64.71%)
$11.98 (11.22%)
102
Buy
117
$15.34 (15.09%)
140
2 months 10 days ago
13/15 (86.67%)
$12.49 (24.95%)
499
Buy
125
$23.34 (22.96%)
122
4 months 12 days ago
13/18 (72.22%)
$15.44 (17.89%)
243
